Publications - W. E . Highsmith, Ph.D.

Back to Research Profile

1. McWilliams RR, Petersen GM, Rabe KG, Holtegaard LM, Lynch PJ, Bishop MD, Highsmith WE Jr. Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations and risk for pancreatic adenocarcinoma. Cancer 2009 Nov 02. [Epub ahead of print]
   View PubMed
2. Kalman L, Wilson JA, Buller A, Dixon J, Edelmann L, Geller L, Highsmith WE, Holtegaard L, Kornreich R, Rohlfs EM, Payeur TL, Sellers T, Toji L, Muralidharan K. Development of genomic DNA reference materials for genetic testing of disorders common in people of ashkenazi jewish descent. J Mol Diagn 2009 Nov; 11(6):530-6. Epub 2009 Oct 08.
   View PubMed
3. Pratt VM, Caggana M, Bridges C, Buller AM, DiAntonio L, Highsmith WE, Holtegaard LM, Muralidharan K, Rohlfs EM, Tarleton J, Toji L, Barker SD, Kalman LV. Development of genomic reference materials for cystic fibrosis genetic testing. J Mol Diagn 2009 May; 11(3):186-93. Epub 2009 Apr 09.
   View PubMed
4. Pratt VM, Caggana M, Bridges C, Buller AM, DiAntonio L, Highsmith WE, Holtegaard LM, Muralidharan K, Rohlfs EM, Tarleton J, Toji L, Barker SD, Kalman LV. Development of genomic reference materials for cystic fibrosis genetic testing. J Mol Diagn 2009 May; 11(3):186-93.
   View PubMed
5. Amos Wilson J, Pratt VM, Phansalkar A, Muralidharan K, Highsmith WE Jr, Beck JC, Bridgeman S, Courtney EM, Epp L, Ferreira-Gonzalez A, Hjelm NL, Holtegaard LM, Jama MA, Jakupciak JP, Johnson MA, Labrousse P, Lyon E, Prior TW, Richards CS, Richie KL, Roa Consensus characterization of 16 FMR1 reference materials: a consortium study. J Mol Diagn 2008 Jan; 10(1):2-12. Epub 2007 Dec 28.
   View PubMed
6. Amos Wilson J, Pratt VM, Phansalkar A, Muralidharan K, Highsmith WE Jr, Beck JC, Bridgeman S, Courtney EM, Epp L, Ferreira-Gonzalez A, Hjelm NL, Holtegaard LM, Jama MA, Jakupciak JP, Johnson MA, Labrousse P, Lyon E, Prior TW, Richards CS, Richie KL, Roa Consensus characterization of 16 FMR1 reference materials: a consortium study. J Mol Diagn 2008 Jan; 10(1):2-12. Epub 2007 Dec 28.
   View PubMed
7. Patkar KA, Highsmith WE, Aldrich JV. Solid phase and solution synthesis of NvocLys [CO(CH2)(5NH)NBD] OCH2(CN), a trifunctional fluorescent lysine derivative. Amino Acids 2008:epub.
   View PubMed
8. Amos Wilson J, Pratt VM, Phansalkar A, Muralidharan K, Highsmith WE Jr, Beck JC, Bridgeman S, Courtney EM, Epp L, Ferreira-Gonzalez A, Hjelm NL, Holtegaard LM, Jama MA, Jakupciak JP, Johnson MA, Labrousse P, Lyon E, Prior TW, Richards CS, Richie KL, Roa B Consensus characterization of 16 FMR1 reference materials: A consortium study. J Mol Diagn 2008; 10(1):2-12.
   View PubMed
9. Pulido JS, Peterson LM, Mutapcic L, Bryant S, Highsmith WE. LOC387715/HTRA1 and complement factor H variants in patients with age-related macular degeneration seen at the mayo clinic. Ophthalmic Genet 2007 Dec; 28(4):203-7.
   View PubMed
10. Highsmith WE Jr, Meyer KJ, Marley VM, Jenkins RB. Conversion Technology for the separation of maternal and paternal copies of any autosomal chromosome in somatic cell hybrids. Curr Protoc Hum Genet 2007 Oct; Chapter 3:Unit 3.6.
    View PubMed
11. Baudhuin LM, Highsmith WE, Skierka J, Holtegaard L, Moore BE, O'Kane DJ. Comparison of three methods for genotyping the UGT1A1 (TA)n repeat polymorphism. Clin Biochem 2007 Jun; 40(9-10):710-7. Epub 2007 Mar 23.
    View PubMed
12. Baudhuin LM, Highsmith WE, Skierka J, Holtegaard L, Moore BE, O'Kane DJ. Comparison of three methods for genotyping the UGT1A1 (TA)n repeat polymorphism. Clin Biochem 2007 Jun; 40(9-10):710-7. Epub 2007 Mar 23.
    View PubMed
13. Margraf RL, Mao R, Highsmith WE, Holtegaard LM, Wittwer CT. RET proto-oncogene genotyping using unlabeled probes, the masking technique, and amplicon high-resolution melting analysis. J Mol Diagn 2007 Apr; 9(2):184-96.
    View PubMed
14. Pulido JS, McConnell JP, Lennon RJ, Bryant SC, Peterson LM, Berger PB, Somers V, Highsmith WE. Relationship between age-related macular degeneration-associated variants of complement factor H and LOC387715 with coronary artery disease. Mayo Clin Proc 2007 Mar; 82(3):301-7.
    View PubMed
15. Jacob EK, Edwards WD, Zucker M, D'Cruz C, Seshan SV, Crow FW, Highsmith WE. Homozygous transthyretin mutation in an African American Male. J Mol Diagn 2007 Feb; 9(1):127-31.
    View PubMed
16. Snyder MR, Katzmann JA, Butz ML, Yang P, Dawson DB, Halling KC, Highsmith WE, Thibodeau SN. Diagnosis of alpha-1-antitrypsin deficiency: An algorithm of quantification, genotyping, and phenotyping. Clin Chem 2006 Dec; 52(12):2236-42.
17. Snyder MR, Katzmann JA, Butz ML, Wiley C, Yang P, Dawson DB, Halling KC, Highsmith WE, Thibodeau SN. Diagnosis of alpha-1-antitrypsin deficiency: An algorithm of quantification, genotyping, and phenotyping. Clin Chem 2006 Dec; 52(12):2236-42. Epub 2006 Oct 19.
    View PubMed
18. Kitzmann AS, Pulido JS, Ferber MJ, Highsmith WE, Babovic-Vuksanovic D. A splice-site mutation in CCM1/KRIT1 is associated with retinal and cerebral cavernous hemangioma. Ophthalmic Genet 2006 Dec; 27(4):157-9.
    View PubMed
19. Uphoff TS, Highsmith WE Jr. Introduction to molecular cystic fibrosis testing. Clin Lab Sci 2006 Winter; 19(1):24-31.
    View PubMed
20. Coffee B, Muralidharan K, Highsmith WE Jr, Lapunzina P, Warren ST. Molecular diagnosis of Beckwith-Wiedemann syndrome using quantitative methylation-sensitive polymerase chain reaction. Genet Med 2006 Oct; 8(10):628-34.
    View PubMed
21. Baudhuin LM, Roberts LR, Enders FT, Swanson RL, Mettler TA, Aderca I, Stadheim LM, Highsmith WE. MYH Y165C and G382D mutations in hepatocellular carcinoma and cholangiocarcinoma patients. J Cancer Res Clin Oncol 2006 Mar; 132(3):159-62. Epub 2005 Nov 15.
    View PubMed
22. Margraf RL, Mao R, Highsmith WE, Holtegaard LM, Wittwer CT. Mutation scanning of the RET protooncogene using high-resolution melting analysis. Clin Chem 2006 Jan; 52(1):138-41.
    View PubMed
23. Cook RJ, Hoyer JD, Highsmith WE. Quintuple alpha-globin gene: a novel allele in a Sudanese man. Hemoglobin 2006; 30(1):51-5.
    View PubMed
24. Barletta JM, Edelman DC, Highsmith WE, Constantine NT. Detection of ultra-low levels of pathologic prion protein in scrapie infected hamster brain homogenates using real-time immuno-PCR. Journal of Virological Methods 2005 Aug; 127(2):154-64.
    View PubMed
25. Abruzzo LV, Wang J, Kapoor M, Medeiros LJ, Keating MJ, Highsmith WE, Barron LL, Cromwell CC, Coombes KR. Biological validation of differentially expressed genes in chronic lymphocytic leukemia identified by applying multiple statistical methods to oligonucleotide microarrays. J Mol Diagn 2005 Aug; 7(3):337-45.
    View PubMed
26. Ahmed SA, Snow-Bailey K, Highsmith WE, Sun WM, Fenwick RG, Mao R. Nine novel germline gene variants in the RET proto-oncogene identified in twelve unrelated cases. J Mol Diagn 2005 May; 7(2):283-8.
    View PubMed
27. Buch JS, Rosenberger F, Highsmith WE, Kimball C, DeVoe DL, Lee CS. Denaturing gradient-based two-dimensional gene mutation scanning in a polymer microfluidic network. Lab on a Chip 2005; 5(4):392-400.
    View PubMed
28. Wang J, Coombes KR, Highsmith WE, Keating MJ, Abruzzo LV. Differences in gene expression between B-cell chronic lymphocytic leukemia and normal B cells: a meta-analysis of three microarray studies. Bioinformatics 2004 Nov 22; 20(17):3166-78.
    View PubMed
29. Buch JS, Kimball C, Rosenberger F, Highsmith WE, DeVoe DL, Lee CS. DNA mutation detection in a polymer microfluidic network using temperature gradient gel electrophoresis. Anal Chem 2004 Feb 15; 76(4):874-81.
    View PubMed
30. Atha DH, Miller K, Xu J, Hess JL, Wu OC, Highsmith WE. High-throughput analysis of telomerase by capillary electrophoresis. Electrophoresis 2003; 24:109-114.
    View PubMed
31. Coombes KR, Highsmith WE, Krogmann TA, Baggerly KA, Stivers DN, Abruzzo LV. Identifying and quantifying sources of variation in microarray data using high-density cDNA membrane arrays. J Comput Biol 2002;9:655-69.
    View PubMed
32. Doyle LA, Highsmith WE. Telomerase as a Diagnostic and Therapeutic Target. Expert review in anticancer therapy 2002;2:217-225.
33. Karp JE, Lancet JE, Kaufmann SH, End DW, Wright JJ, Bol K, Horak I, Tidwell ML, Liesveld J, Kottke TJ, Ange D, Buddharaju L, Gojo I, Highsmith WE, Belly RT, Hohl RJ, Rybak ME, Thibault A, Rosenblatt J. Clinical and biologic activity of the farnesyltransferase inhibitor R115777 in adults with refractory and relapsed acute leukemias: a phase 1 clinical-laboratory correlative trial. Blood 2001 Jun 1; 97(11):3361-9.
    View PubMed
34. Ramdas L, Coombes KR, Baggerly K, Abruzzo L, Highsmith WE, Krogmann T, et al. Sources of nonlinearity in cDNA microarray expression measurements. Genome Biol 2001;2:11.
    View PubMed
35. King J, Treanor J, Fast P, Wolf M, Iacuzio M, Highsmith W, et al. Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A & B, live cold-adapted, administered to HIV-infected and non-HIV-infected adults. J Infect Dis 2000;181:725-8.
    View PubMed
36. Highsmith WE, Jin Q, Nataraj AJ, O’Conner JM, Burland VD, Baubonis WH, et al. Use of a DNA toolbox for the characterization of mutation scanning methods - construction of the toolbox and evaluation of heteroduplex analysis. Electrophoresis 1999;20:1186-94.
    View PubMed
37. Nataraj AJ, Olivos-Glander I, Kusukawa1 N, Highsmith WE. SSCP and heteroduplex analysis for gel based mutation detection. Electrophoresis 1999;20:1177-1185.
38. Highsmith WE, Nataraj AJ, Jin Q, O'Connor JM, El-Nabi SH, Kusukawa N, Garner MM. Use of DNA toolbox for the characterization of mutation scanning methods. II: evaluation of single-strand conformation polymorphism analysis. Electrophoresis 1999;20:1195-203.
39. Stroval J, Abruzzo L, Highsmith WE, Stamberg J. Quantitative measurement of telomerase activity in lymphadenopathy: correlation with histologic features and human immunodeficiency virus-1 infection. Mod Pathol 1998;11:957-62.
    View PubMed
40. Hsu I, Highsmith WE, Xu J, Kong D. Mismatch cleavage detects base deletion in cystic fibrosis gene. BioTechniques 1998;25:692-696.
41. Abdel-Hamid M, Edelman DC, Highsmith WE, Constantine NT. Optimization, assessment, and proposed use of a direct nested RT-PCR protocol for the increased detection of hepatitis C virus. Hum Virology 1997;1:58-65.
42. Highsmith WE, Strong T, Smith T, Silverman LM, Collins FS, Boucher R, Knowles MR. A splice site mutation in the CFTR gene from a consanguineous family with mild cystic fibrosis. Hum Mutat 1997;9:332-338.
    View PubMed
43. Stoerker J, Hurwitz C, Rose N, Highsmith WE. Heteroduplex analysis for prenatal blood group analysis. Clin Chem 1996;42: 356-360.
    View PubMed
44. Friedman KJ, Teichtahl H, de Krester DM, Temple-Smith P, Southwick GJ, Silverman LM, Highsmith WE, et al. Screening Young syndrome patients for CFTR mutations. Am J Pulm Crit Care Med 1995;152:1353-1357.
45. Lench NJ, Athma P, Ottaiano A, Sribney WM, Highsmith WE, Swift M. The DNA marker D11S384 shows zero recombination with the ataxia-telangiectasia locus in North American families. Intl J Radiat Biol 1995;66(Suppl6):S67-9.
46. Prior TW, Demmler G, Papp AC, Synder PJ, Highsmith WE. Rapid haplotyping by heteroduplex analysis. Hum Mutat 1995;5:263-268.
    View PubMed
47. Highsmith WE, Burch L, Boat TE, Spock A, Gorvoy J, Quittell L, et al. A novel cystic fibrosis gene mutation is common in patients with normal sweat chloride values. N Engl J Med 1994;331:974-80.
    View PubMed
48. Kiesewetter S, Macek M, Curristan SM, Chu CS, Trapnell BC, Highsmith WE, et al. A mutation in the cystic fibrosis transmembrane regulator gene produces different phenotypes depending on genetic background. Nat Genet 1993;5:274-8.
    View PubMed
49. The Cystic Fibrosis Genotype-Phenotype Consortium. Correlation between genotype and phenotype in patients with cystic fibrosis. N Engl J Med 1993;329:1308-13.
    View PubMed
50. Highsmith WE. Carrier studies in cystic fibrosis. Clin Chem 1993;39:706-707.
51. Hopfer R, Walden P, Sutterquis S, Highsmith WE. Detection and identification of pathogenic fungi using the polymerase chain reaction and restriction digest analysis. Med Vet Mycology 1993;31:65-75.
52. Osborn L, Santis G, Schwarz M, Klinger K, Dork T, Highsmith WE, et al. Incidence and expression of the N1303K mutation of the cystic fibrosis (CFTR) gene. Hum Genet 1992;89:653-658.
53. Kilby JM, Gilligan PH, Yankaskas JR, Highsmith WE, Edwards L, Knowles MR. Nontuberculosis mycobacteria in adult patients with cystic fibrosis. Chest 1992;102:70-75.
    View PubMed
54. Forman DT, Bankson DD, Highsmith WE. Neonatal screening for serum biotinidase activity. Ann Clin Lab Sci 1992;22:144-154.
    View PubMed
55. Friedman KJ, Highsmith WE, Silverman LM. Detection of multiple cystic fibrosis mutations using PCR-mediated site-directed mutagenesis. Clin Chem 1991;37:753-755.
    View PubMed
56. Highsmith WE Jr, Chong GL, Orr HT, Perry TR, Schald D, Farber R, Wagner K, Knowles MR, Thibodeau SN, et al. Frequency of the delta-Phe508 mutation and correlation with XV.2c/KM-19 haplotypes in an American population of cystic fibrosis patients: results of a collaborative study. Clin Chem 1990 Oct; 36:1741-6.
57. Prior TW, Papp AC, Snider PJ, Highsmith WE, Friedman KJ, Perry TR, et al. Determination of carrier status in Duchenne and Becker muscular dystrophies by quantitative polymerase chain reaction and allele-specific oligonucleotides. Clin Chem 1990;36:2113-2117.
58. Prior TW, Highsmith WE, Friedman KJ, Perry TR, Scheuerbrandt G, Silverman LM. A model for molecular screening of newborns: simultaneous detection of DMD/BMD muscular dystrophies and cystic fibrosis. Clin Chem 1990;36:1756-1759.
59. The Cystic Fibrosis Genetic Analysis Consortium. Worldwide survey of the Delta F508 mutation. Am J Hum Genet 1990;47:354-359.
60. Prior TW, Friedman KJ, Highsmith WE, Perry TR, Silverman LM. A molecular protocol for the determination of carrier status in Duchenne and Becker muscular dystrophies. Clin Chem 1990;36: 441-445.
61. Friedman KJ, Highsmith WE, Prior TW, Perry TR, Silverman LM. Detection of the cystic fibrosis deletion mutation using PCR mediated site-directed mutagenesis. Clin Chem 1990;36:695-696.
62. McConkie-Rosell A, Chen YT, Harris D, Speer MC, Periak-Vance MA, Ding JH, Highsmith WE, et al. Mild cystic fibrosis linked to chromosome 7q22 markers with an uncommon haplotype. Ann Intern Med 1989;111:797- 801.
63. Highsmith WE, Silverman LM. Clinical utility of the polymerase chain reaction. Bull Lab Med 1989;104:1-4.
64. Highsmith WE, Perry TR, Prior TW, Silverman LM. Use of the polymerase chain reaction for the simultaneous analysis of two Pst I polymorphisms linked to cystic fibrosis. Clin Chem 1989 Jun;35(6):1260-1.
    View PubMed
65. Highsmith WE, Hyde PM. Improved enzymatic hydrolysis of conjugated bile acids. Lipids 1987;22:61-3.
    View PubMed
66. Davis RA, Highsmith WE, McNeal MM, Schexnayder JA, Kuan JW. Bile acid synthesis by cultured hepatocytes: Inhibition of mevinolin, but not by bile acids. J Biol Chem 1983;258:4079-82.
    View PubMed
67. Margraf RL, Mao R, Highsmith WE, Holtegaard LM, Wittwer CT. RET Proto-Oncogene Genotyping Using Unlabeled Probes, the Masking Technique, and Amplicon High-Resolution Melting Analysis. J Mol Diagn 2007; 9(2):184-196.
    View PubMed
68. Pulido JS, McConnell JP, Lennon RJ, Bryant SC, Peterson LM, Berger PB, Somers V, Highsmith WE. Relationship between age-related macular degeneration-associated variants of complement factor H and LOC387715 with coronary artery disease. Mayo Clin Proc 2007; 82(3):301-307.
    View PubMed